Post‐transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)
Abstract
Data are scarce regarding employment outcomes of survivors of childhood allogeneic hematopoietic cell transplantation (alloHCT) and the factors that affect their employment status.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 12, 2018
- Source ID
- 10.1002/cncr.31781
Entities
People
- Bronwen E Shaw
- Heather R Tecca
- Jeanette Carreras
- Julie‐an M. Talano
- Karen L. Syrjala
- Linda J. Burns
- Neel S Bhatt
- Rachel B. Salit
- Rachel Phelan
- Ruta Brazauskas
Organizations
- Actinium Pharmaceuticals (United States)
- Astellas Pharma (United States)
- AstraZeneca (United States)
- Celgene
- Chiron Corporation
- Fred Hutchinson Cancer Center
- Gilead Sciences
- Health Resources and Services Administration
- HistoGenetics (United States)
- Jazz Pharmaceuticals
- Karyopharm Therapeutics (United States)
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Otsuka Pharmaceutical
- Patient-Centered Outcomes Research Institute
- Pfizer
- Seagen
- Shire plc
- Spectrum Pharmaceuticals
- University of Minnesota
- University of Washington